Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ömer Yazici"'
Autor:
Ömer Yazıcı
Today, one of the most valuable assets of companies is their workforce. Primarily, the importance of information is increased and the human factor that absorbs and uses it by creating value has become much more essential. One of the most critical ste
Publikováno v:
Kulak Burun Boğaz ve Baş Boyun Cerrahisi Dergisi. 28:173-180
Autor:
Ayca Ant, Semih Ak, Nazan Bozdogan, Tuncay Tunçcan, Samet Ozlugedik, Ömer Yazici, Yahya Baltu, Caner Kiliç
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 128:541-547
Objectives:Platelet-rich plasma (PRP) was administered into the temporomandibular joint (TMJ) space, which had been exposed to radiotherapy (RT), in an attempt to prevent and/or treat the late-term complications associated with RT when used for the t
Autor:
Utku Aydil, Ozge Gumusay, Fakih Cihat Eravcı, Ramazan Yildiz, Mehmet Ekrem Zorlu, Ahmet Köybaşioğlu, Faruk Kadri Bakkal, Müge Akmansu, Ömer Yazici, Yusuf Kizil
Publikováno v:
Ear, nose,throat journal. 98(7)
Although definitive chemoradiation (CRT) has been used for locally advanced laryngeal cancer for more than 2 decades, studies focusing on CRT failures in advanced laryngeal cancer are scarce. In this study, we aimed to determine the failure patterns
Autor:
Müge Akmansu, Utku Aydil, Yusuf Kizil, Ozge Gumusay, Ahmet Köybaşioğlu, Ömer Yazici, Faruk Kadri Bakkal, Suleyman Buyukberber, Erdoğan Inal, Ramazan Yildiz
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 273:2795-2803
During last decades, laryngeal organ preservation strategies have emerged. The data about the oncological outcomes mainly come from multi-institutional prospective studies. In this study, we aimed to determine the oncological outcomes of different or
Publikováno v:
Business & Management Studies: An International Journal, Vol 6, Iss 1 (2018)
This paper is designed to explore whether family businesses outperform nonfamily businesses regarding Corporate Social Responsibility (CSR) performance. Upon comparing the CSR performances of 64 top family businesses in the US with CSR performances o
Autor:
Vildan Kutay Bozkurt, Ömer Yazici
Publikováno v:
Volume: 0, Issue: 11 79-106
Sosyal Güvence
Sosyal Güvence Dergisi, Vol 0, Iss 11, Pp 80-106 (2017)
Sosyal Güvence
Sosyal Güvence Dergisi, Vol 0, Iss 11, Pp 80-106 (2017)
Ekonomik değerlendirme yöntemleri yardımıyla yapılan analizler sayesinde sağlıkalanındaki politika yapıcılara karar sürecinde bilgi sağlanmakta ve alınacak kararlarınbilimsel temellere oturtulabilmesi açısından tavsiye verici ve düz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46803c1bc8149a893b0ba4309ad2e47
https://dergipark.org.tr/tr/pub/sosyalguvence/issue/28407/302235
https://dergipark.org.tr/tr/pub/sosyalguvence/issue/28407/302235
Autor:
Aydin Ciltas, Burcu Yapar Taskoylu, Utku Oflazoglu, Mustafa Benekli, Murat Akyol, Mehmet Metin Seker, Ayse Ocak Duran, Alper Sevinc, Muhammed Bulent Akinci, Aziz Karaoglu, Sener Cihan, Caglayan Geredeli, Hilmi Kodaz, Umut Kefeli, Ömer Yazici, Didem Tastekin, Banu Ozturk, Umut Demirci, Mukremin Uysal, Suleyman Buyukberber
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL
WOS: 000358613200846
…
Amer Soc Clin Oncol
WOS: 000358613200846
…
Amer Soc Clin Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db71f89fcbfcd880fa44c441c2593058
https://avesis.gazi.edu.tr/publication/details/b943632d-8f96-40be-80e8-b5640abc8970/oai
https://avesis.gazi.edu.tr/publication/details/b943632d-8f96-40be-80e8-b5640abc8970/oai
Autor:
Alper Sevinc, Ilhan Oztop, Mehmet Kucukoner, Mevlude Inanc, Ömer Yazici, Abdurrahman Isikdogan, Ali Suner, Tulay Eren, Dogan Koca, Zuhat Urakci, Olcun Umit Unal, Muhammet Ali Kaplan
Publikováno v:
Journal of Clinical Oncology. 31:e18546-e18546
e18546 Background: Small cell lung cancers (SCLC) constitute a mean of 15% of lung cancers and present with advanced disease at time of diagnosis in 60% of cases. Cisplatin plus etoposide schedule is the standard treatment in these patients , whereas
Autor:
AKMANSU, Müge1 mugeakmansu@gmail.com, KILIÇ, Diclehan1, AKYÜREK, Serap2, AKBÖRÜ, Halil3, ARICAN ALICIKUŞ, Lütfiye Zümre4, YALMAN, Deniz5, YAZICI, Ömer6, KEVEN, Emine6, ATALAR, Banu7, YÜRÜT ÇALOĞLU, Vuslat8, GÜRSEL, Şükriye Bilge9, KURT, Meral10, İĞDEM, Mehmet Şefik11, KAYTAN SAĞLAM, Esra12
Publikováno v:
Turkish Journal of Oncology / Türk Onkoloji Dergisi. 2022, Vol. 37 Issue 3, p321-328. 8p.